NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled
NCT03604783 2024-09-19Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsSumitomo Pharma America, Inc.Phase 1 Terminated74 enrolled